Druckenmiller’s Bet: From AI Heights to Teva’s Gamble
Billionaire Stanley Druckenmiller, managing over $4 billion at Duquesne Family Office, offers one such pattern. Over the past year, he exited Palantir Technologies entirely-a 770,000-share position-and doubled down on Teva Pharmaceutical Industries across four consecutive quarters. This is not random trading. It is signal, not noise.